- Home
- ATAI vs RIV Comparison
ATAI vs RIV Comparison
Compare ATAI & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.42
Company Overview
Basic Information| Metric | ATAI | RIV |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 329.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATAI | RIV |
|---|---|---|
| Price | $3.42 | $11.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 86.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,000.00 | N/A |
| Revenue This Year | $955.84 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $10.11 |
| 52 Week High | $6.73 | $12.56 |
Technical Indicators
Market Signals| Indicator | ATAI | RIV |
|---|---|---|
| Relative Strength Index (RSI) | 39.75 | 32.36 |
| Support Level | $1.29 | $11.57 |
| Resistance Level | $4.40 | $11.81 |
| Average True Range (ATR) | 0.28 | 0.10 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 4.57 | 14.63 |
Price Performance
Historical Comparison ATAI
RIV
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.